IMPULSE StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE A Prospective, Multi-center, Randomized, Double-blind Study to Assess Efficacy and Safety of Neuroplastic Intervention by Cerebrolysin and atDCS on Motor Function Recovery in Subacute and Chronic Stroke Patients
Latest Information Update: 05 Aug 2022
At a glance
- Drugs FPF 1070 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms IMPULSE
- Sponsors EVER Neuro Pharma
Most Recent Events
- 26 Jul 2022 Status changed from recruiting to discontinued for strategic and pandemic reasons.
- 28 Jun 2021 Planned End Date changed from 1 Aug 2023 to 31 Dec 2022.
- 28 Jun 2021 Planned primary completion date changed from 1 May 2022 to 31 Dec 2022.